Most GLP-1 receptor agonists carry a boxed warning for thyroid C-cell tumors and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
However, its specific mechanism is still unclear, and added research is warranted
BPC-157 and Erectile Dysfunction Erectile dysfunction is attributable to several different causes, classified as vasculogenic, psychogenic, endocrinologic, or neurologic
Tirzepatide is an FDA-approved drug with completed Phase 3 obesity trials, while cagrilintide is investigational, with monotherapy data only through Phase 2 and its strongest results coming from the CagriSema combination
I recently got on it & I can already see the results. Jul 10, 2026 LOVE GoodGirlRx